First drug granted approval under FDA’s Limited Population Pathway for Antibacterial and Antifungal Drugs (Image: Bronchiectasis News Today)
Gold and other precious metals are heading higher again and cementing their status as an ongoing safe haven in time of volatility. Samaranta Mining Corporation (SAX.TSXV) is doing its best to
Company chart and information is provided by TradingView based on 15-minute-delayed data.
Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension.
| Website: | www.insmed.com |
| Email: | investor.relations@insmed.com |
| Main Phone: | +1 908 977-9900 |
| Address: | 700 US Highway 202/206 |
| Address 2: | Building 202/206 |
| State: | NJ |
| City / Town: | Bridgewater |
| Country: | US |
| Postal Code: | 08807 |
| Exchange: | NGS |
| CEO: | William Lewis |
| Employees: | 521 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
First drug granted approval under FDA’s Limited Population Pathway for Antibacterial and Antifungal Drugs (Image: Bronchiectasis News Today)
Gold and other precious metals are heading higher again and cementing their status as an ongoing safe haven in time of volatility. Samaranta Mining Corporation (SAX.TSXV) is doing its best to
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
